These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 1577459)
1. Alport syndrome caused by a 5' deletion within the COL4A5 gene. Renieri A; Seri M; Myers JC; Pihlajaniemi T; Sessa A; Rizzoni G; De Marchi M Hum Genet; 1992 Apr; 89(1):120-1. PubMed ID: 1577459 [TBL] [Abstract][Full Text] [Related]
2. Alport syndrome and diffuse leiomyomatosis: deletions in the 5' end of the COL4A5 collagen gene. Antignac C; Zhou J; Sanak M; Cochat P; Roussel B; Deschênes G; Gros F; Knebelmann B; Hors-Cayla MC; Tryggvason K Kidney Int; 1992 Nov; 42(5):1178-83. PubMed ID: 1453602 [TBL] [Abstract][Full Text] [Related]
3. Deletions of the COL4A5 gene in patients with Alport syndrome. Netzer KO; Renders L; Zhou J; Pullig O; Tryggvason K; Weber M Kidney Int; 1992 Dec; 42(6):1336-44. PubMed ID: 1474765 [TBL] [Abstract][Full Text] [Related]
4. Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Barker DF; Hostikka SL; Zhou J; Chow LT; Oliphant AR; Gerken SC; Gregory MC; Skolnick MH; Atkin CL; Tryggvason K Science; 1990 Jun; 248(4960):1224-7. PubMed ID: 2349482 [TBL] [Abstract][Full Text] [Related]
5. Major COL4A5 gene rearrangements in patients with juvenile type Alport syndrome. Renieri A; Galli L; Grillo A; Bruttini M; Neri T; Zanelli P; Rizzoni G; Massella L; Sessa A; Meroni M; Peratoner L; Riegler P; Scolari F; Mileti M; Giani M; Cossu M; Savi M; Ballabio A; De Marchi M Am J Med Genet; 1995 Nov; 59(3):380-5. PubMed ID: 8599366 [TBL] [Abstract][Full Text] [Related]
6. Alport syndrome. Molecular genetic aspects. Hertz JM Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970 [TBL] [Abstract][Full Text] [Related]
7. DNA rearrangements in the alpha 5(IV) collagen gene (COL4A5) of individuals with Alport syndrome: further refinement using pulsed-field gel electrophoresis. Vetrie D; Boye E; Flinter F; Bobrow M; Harris A Genomics; 1992 Nov; 14(3):624-33. PubMed ID: 1330889 [TBL] [Abstract][Full Text] [Related]
8. Major rearrangements in the alpha 5(IV) collagen gene in three patients with Alport syndrome. Boye E; Vetrie D; Flinter F; Buckle B; Pihlajaniemi T; Hamalainen ER; Myers JC; Bobrow M; Harris A Genomics; 1991 Dec; 11(4):1125-32. PubMed ID: 1783380 [TBL] [Abstract][Full Text] [Related]
9. Deletions in the COL4A5 collagen gene in X-linked Alport syndrome. Characterization of the pathological transcripts in nonrenal cells and correlation with disease expression. Antignac C; Knebelmann B; Drouot L; Gros F; Deschênes G; Hors-Cayla MC; Zhou J; Tryggvason K; Grünfeld JP; Broyer M J Clin Invest; 1994 Mar; 93(3):1195-207. PubMed ID: 8132760 [TBL] [Abstract][Full Text] [Related]
11. [Detection of large deletions in X linked Alport syndrome using competitive multiplex fluorescence polymerase chain reaction]. Wang F; Zhang YQ; Ding J; Yu LX Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 49(5):760-767. PubMed ID: 29045953 [TBL] [Abstract][Full Text] [Related]
13. A TaqI RFLP in the type IV collagen alpha 5 chain gene (COL4A5) with the rare allele more frequently found in seven Chinese Alport syndrome patients. Chan SY; Wong SN; Lau YL Clin Genet; 1995 May; 47(5):278-9. PubMed ID: 7554358 [No Abstract] [Full Text] [Related]
14. Dot-and-fleck retinopathy in Alport syndrome caused by a novel mutation in the COL4A5 gene. Blasi MA; Rinaldi R; Renieri A; Petrucci R; De Bernardo C; Bruttini M; Grammatico P Am J Ophthalmol; 2000 Jul; 130(1):130-1. PubMed ID: 11004279 [TBL] [Abstract][Full Text] [Related]
15. An 8 bp deletion in exon 51 of the COL4A5 gene of an Alport syndrome patient. Boye E; Flinter FA; Bobrow M; Harris A Hum Mol Genet; 1993 May; 2(5):595-6. PubMed ID: 8518800 [No Abstract] [Full Text] [Related]
16. Deletions of both alpha 5(IV) and alpha 6(IV) collagen genes in Alport syndrome and in Alport syndrome associated with smooth muscle tumours. Heidet L; Dahan K; Zhou J; Xu Z; Cochat P; Gould JD; Leppig KA; Proesmans W; Guyot C; Guillot M Hum Mol Genet; 1995 Jan; 4(1):99-108. PubMed ID: 7711741 [TBL] [Abstract][Full Text] [Related]
17. De novo mutation in the COL4A5 gene converting glycine 325 to glutamic acid in Alport syndrome. Renieri A; Seri M; Myers JC; Pihlajaniemi T; Massella L; Rizzoni G; De Marchi M Hum Mol Genet; 1992 May; 1(2):127-9. PubMed ID: 1363780 [TBL] [Abstract][Full Text] [Related]
18. Alport syndrome: a genetic study of 31 families. M'Rad R; Sanak M; Deschenes G; Zhou J; Bonaiti-Pellie C; Holvoet-Vermaut L; Heuertz S; Gubler MC; Broyer M; Grunfeld JP Hum Genet; 1992 Dec; 90(4):420-6. PubMed ID: 1483700 [TBL] [Abstract][Full Text] [Related]
19. A deletion mutation in the 3' end of the alpha 5(IV) collagen gene in juvenile-onset Alport syndrome. Saito A; Sakatsume M; Yamazaki H; Ogata F; Hirasawa Y; Arakawa M J Am Soc Nephrol; 1994 Mar; 4(9):1649-53. PubMed ID: 8011973 [TBL] [Abstract][Full Text] [Related]
20. Absence of the alpha6(IV) chain of collagen type IV in Alport syndrome is related to a failure at the protein assembly level and does not result in diffuse leiomyomatosis. Zheng K; Harvey S; Sado Y; Naito I; Ninomiya Y; Jacobs R; Thorner PS Am J Pathol; 1999 Jun; 154(6):1883-91. PubMed ID: 10362815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]